Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL
Launched by UNIVERSITY OF CONNECTICUT · Jul 26, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Family ASL study is looking at how deaf and hard of hearing children learn American Sign Language (ASL) and how their hearing parents can support this learning. The goal is to understand the development of ASL skills in these children over time. The study is currently recruiting participants, specifically focusing on children aged 2 years old at the start of the study and their adult caregivers.
To be eligible, children must be deaf or hard of hearing and enrolled in a program that teaches both ASL and spoken language. Each child needs to have one adult caregiver who will participate in the study. However, families with other diagnosed conditions that might affect a child's language or thinking skills, or those without internet access, will not be included. Participants can expect to engage in activities that help track and support the child's ASL development, contributing valuable information to improve resources for families like theirs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Children:
- • Children ages 2;00 - 2;11 at the start of the longitudinal project
- • Child is Deaf/ Hard-of-Hearing
- • Participating in a program utilizing a bimodal bilingual philosophy
- Adults:
- • - One adult caregiver for each child
- Exclusion Criteria:
- • Children with previously-diagnosed conditions other than deafness known to affect language and cognitive development
- • Families without access to internet (at home or other locations)
About University Of Connecticut
The University of Connecticut (UConn) is a leading academic institution committed to advancing health and science through innovative research and education. As a clinical trial sponsor, UConn leverages its extensive resources, including renowned faculty and state-of-the-art facilities, to conduct rigorous studies that contribute to medical knowledge and improve patient care. The university fosters a collaborative environment, engaging multidisciplinary teams to explore novel therapies and interventions across various health-related fields. UConn's dedication to ethical practices and compliance ensures the integrity and reliability of its clinical research, ultimately aiming to enhance health outcomes and address critical challenges in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Storrs, Connecticut, United States
Patients applied
Trial Officials
Diane C Lillo-Martin, Ph.D.
Principal Investigator
University of Connecticut
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials